The Italian Ministry of Health has allowed the AstraZeneca vaccine developed against the new type of corona virus (Covid-19) to be used for over 65 years of age.
In the statement made by the Ministry of Health, it was stated that the Ministry’s Epidemic Prevention Manager Gianni Rezza signed the circular on the use of AstraZeneca vaccine in people over 65 years of age, excluding those who have a weak immune system that increases the risk of death of Covid-19 or those who take drugs for other diseases.
In the statement, behind this decision; It was stated that the scientific data obtained on the AstraZeneca vaccine proved that the vaccine was safe and also showed that this vaccine could provide significant protection against the development of the disease in subjects over 65 years of age.
After the European Medicines Agency (EMA) approved AstraZeneca on January 29, the Italian Medicines Agency (AIFA) also approved the AstraZeneca vaccine for use in those aged between 18 and 55 at the first stage, according to reports in the Italian press.
In Italy, where the widespread vaccination campaign against Covid-19 started on December 27, 2020, 5 million 417 thousand 678 people have been vaccinated as of today. A second dose of Covid-19 vaccine was administered to 1 million 652 thousand 31 of these people.
Health Minister Roberto Speranza also made a statement on the television program on 7 March, signaling that the vaccine supplies will accelerate as of April and stated that they aim to vaccinate all Italians who want to be vaccinated by summer.